Semicochliodinol A and B: Inhibitors of HIV-1 protease and EGF-R protein tyrosine kinase related to asterriquinones produced by the fungus Chrysosporium merdarium

Journal of Antibiotics

Volumn 50, Issue 5, 1997, Pages 395-401

  Fredenhagen, Andreas ^a   Petersen, Frank ^a   Tintelnot Blomley, Marina ^a   Rösel, Johannes ^a   Mett, Helmut ^a   Hug, Paul ^a  

^a CIBA GEIGY LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; PROTEINASE INHIBITOR; SEMICOCHLIODINOL A; SEMICOCHLIODINOL B; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG ISOLATION; DRUG POTENCY; DRUG PURIFICATION; DRUG STRUCTURE; FERMENTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR MODEL; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0031005987     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.50.395     Document Type: Article

References (20)

1. JOHNSON, V. A.: New Developments in Antiviral Drug Therapy for HIV-1 infections. In AIDS Clinical Review 1995/1996. Ed., P. VOLBERDING et al., pp. 307-337, Marcel Dekker Inc., New York, 1996
2. HANAFUSA, H.; B. J. MAYER, C. REICHMAN & M. HAMAGUCHI: Cell transformation by an oncogene that regulates protein kinases. In Advances in second messenger and phosphoprotein research. The biology and medicine of signal transduction. Ed., Y. NISHIZUKA et al., pp. 280-283, Raven Press, New York, 1990
3. HONEGGER, A. M.; T. J. DULL, S. FELDER, E. VAN OBBERGHEN, F. BELLOT, D. SZAPARY, A. SCHMIDT, A. ULLRICH & J. SCHLESSINGER: Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing. Cell 51: 199-209, 1987
4. COZENS, R.; G. BOLD, H. G. CAPRARO, A. FÄSSLER, M. LANG, J. MESTAN, B. PONCIONI, D. STOVER & J. L. RÖSEL: Synthesis and pharmacological evaluation of HIV-1 protease inhibitors from the Phe-c-Phe peptidomimetic class. Antiviral Chem. and Chemotherapy 7: 294-299, 1996
5. MCGLYNN, E.; M. BECKER, H. METT, S. REUTENER, R. COZENS & N. B. LYDON: Large-scale purification and characterization of a recombinant epidermal growth-factor receptor protein-tyrosine kinase. Modulation of activity by multiple factors. Eur. J. Biochem. 207: 265-275, 1992
6. MEYER, T.; U. REGENASS, D. FABBRO, E. ALTERI, J. RÖSEL, M. MÜLLER, G. CARAVATTI & A. MATTER: A derivative of staurosporine (CGP 41251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumor activity. Int. J. Cancer 43: 851-856, 1989
7. MOHAMADI, F.; N. G. J. RICHARDS, W. C. GUIDA, R. LISKAMP, M. LIPTON, C. CAUFIELD, G. CHANG, T. HENDRICKSON & W. C. STILL: MacroModel - An integrated software system for modeling organic and bioorganic molecules using molecular mechanics. J. Comput. Chem. 11: 440, 1990
8. PRIESTLE, J. P.; A. FÄSSLER, J. RÖSEL, M. TINTELNOT-BLOMLEY, P. STROP & M. G. GRÜTTER: A comparative analysis of HIV-1 and HIV-2 proteases complexed with CGP53820, a novel pseudosymmetric inhibitor. Structure 3: 381, 1995
9. LANG, M.; E. ALTERI, W. BECK, G. BOLD, E. BOSS, R. COZENS, F. CUMIN, A. FÄSSLER, M. GRÜTTER, E. HUNGERBÜHLER, T. KLIMKAIT, J. LAZDINS, B. PONCIONI, J. L. RÖSEL, H. RÜEGER, P. SCHNEIDER, M. TINTELNOT-BLOMLEY, M. WALKER & K. WOODS-COOK: From renin inhibitors to CGP53437, a novel orally bioavailable HIV-1 protease inhibitor, Abstract of the IXth International Conference on AIDS, Berlin, June 7-11, 1993, Abstract A25-0559
10. SEKITA, S.: Isocochliodinol and neocochliodinol, bis(3-indolyl)-benzoquinones from Chaetomium spp. Chem. Pharm. Bull. 31: 2998-3001, 1983
11. DAVIS, A. L.; J. KEELER, E. D. LAUE & D. MOSKAU: Experiments for the recording of pure-absorption heteronuclear correlation spectra using pulsed field gradients. J. Magn. Reson. 98: 207-216, 1992
12. 13C assignments from sensitivity-enhanced detection of heteronuclear multiple-bond connectivity by 2D multiple quantum NMR. J. Am. Chem. Soc. 108: 2093-2094, 1986
13. ARAI, K.; S. SHIMIZU, Y. TAGUCHI & Y. YAMAMOTO: Metabolic products of Aspergillus terreus. V. Demethylation of asterriquinones. Chem. Pharm. Bull. 29: 991-999, 1981
14. ARAI, K.; K. MASUDA, N. KIRIYAMA, K. NITTA, Y. YAMAMOTO & S. SHIMIZU: Metabolic products of Aspergillus terreus. IV. Metabolites of the strain IFO 8835. (2). The isolation and chemical structure of indolyl benzoquinone pigments. Chem. Pharm. Bull. 29: 961-969, 1981
15. SHIMIZU, S.; Y. YAMAMOTO & S. SABURO: Antitumor activity of asterriquinones from Aspergillus fungi. IV. An attempt to modify the structure of asterriquinones to increase the activity. Chem. Pharm. Bull. 30: 1896-1899, 1982
16. LAM, P. Y. S.; P. K. JADHAV, C. J. EYERMANN, C. N. HODGE, Y. RU, L. T. BACHELER, J. L. MEEK, M. J. OTTO, M. M. RAYNER, Y. N. WONG, C.-H. CHANG, P. C. WEBER, D. A. JACKSON, T. R. SHAPE & S. ERICKSON-VITANEN: Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors. Science 263: 380, 1994
17. VARA PRASAD, J. V. N.; K. S. PARA, E. A. LUNNEY, D. F. ORTWINE, J. B. DUNBAR, D. FERGUSON, P. J. TUMMINO, D. HUPE, B. D. TAIT, J. M. DOMAGALA, C. HUMBLET, T. N. BHAT, B. LIU, D. M. A. GUERIN, E. T. BALDWIN, J. W. ERICKSON & T. K. SAWYER: Novel series of achiral, low molecular weight, and potent HIV-1 protease inhibitors. J. Am. Chem. Soc. 116: 6989, 1994
18. ROMINES, K. R. & R. A. CHRUSCIEL: 4-Hydroxypyrones and related templates as nonpeptidic HIV protease inhibitors. Current Medicinal Chemistry 2: 825, 1995
19. KOBAYASHI, J.; T. MADONO & H. SHIGEMORI: Nakijiquinones C and D, new sesquiterpenoid quinones with a hydroxy amino acid residue from a marine sponge inhibiting c-erbB-2 kinase. Tetrahedron 51: 10867-10874, 1995
20. TRINKS, U.; E. BUCHDUNGER, P. FURET, W. KUMP, H. METT, T. MEYER, M. MÜLLER, U. REGENASS, G. RIHS, N. B. LYDON & P. TRAXLER: Dianilinophtalimides: Potent and selective, ATP-competitive inhibitors of the EGF-receptor protein tyrosine kinase. J. Med. Chem. 37: 1015-1027, 1994